5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and mizoribine

5-ethynyl-1-ribofuranosylimidazole-4-carboxamide has been researched along with mizoribine in 2 studies

Compound Research Comparison

Studies (5-ethynyl-1-ribofuranosylimidazole-4-carboxamide)	Trials (5-ethynyl-1-ribofuranosylimidazole-4-carboxamide)	Recent Studies (post-2010) (5-ethynyl-1-ribofuranosylimidazole-4-carboxamide)	Studies (mizoribine)	Trials (mizoribine)	Recent Studies (post-2010) (mizoribine)
21	0	2	584	75	184

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Shigeta, S	1
Bailey, K; Barnard, DL; Carson, DA; Cottam, HB; Day, CW; Heiner, M; Hoopes, J; Lauridsen, L; Lee, J; Li, JK; Montgomery, R; Sidwell, RW; Winslow, S	1

Reviews

1 review(s) available for 5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and mizoribine

Article	Year
Recent progress in antiviral chemotherapy for respiratory syncytial virus infections. Expert opinion on investigational drugs, 2000, Volume: 9, Issue:2 Topics: Amides; Animals; Antibodies, Monoclonal; Antiviral Agents; Biopolymers; Bridged-Ring Compounds; Catechin; Drugs, Investigational; Heterocyclic Compounds; Humans; Immunoglobulins, Intravenous; Lipids; N-Acetylneuraminic Acid; Norbornanes; Oligodeoxyribonucleotides, Antisense; Pyrazoles; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Ribonucleosides; Ribose; Risk Factors; Thiocarbamates; Thiones	2000

Article

Year

Recent progress in antiviral chemotherapy for respiratory syncytial virus infections.

Expert opinion on investigational drugs, 2000, Volume: 9, Issue:2

Topics: Amides; Animals; Antibodies, Monoclonal; Antiviral Agents; Biopolymers; Bridged-Ring Compounds; Catechin; Drugs, Investigational; Heterocyclic Compounds; Humans; Immunoglobulins, Intravenous; Lipids; N-Acetylneuraminic Acid; Norbornanes; Oligodeoxyribonucleotides, Antisense; Pyrazoles; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Ribonucleosides; Ribose; Risk Factors; Thiocarbamates; Thiones

2000

Other Studies

1 other study(ies) available for 5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and mizoribine

Article	Year
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin. Antiviral research, 2006, Volume: 71, Issue:1 Topics: Animals; Antiviral Agents; Caco-2 Cells; Cell Survival; Chlorocebus aethiops; Cytokines; Cytopathogenic Effect, Viral; Female; Humans; IMP Dehydrogenase; Lung; Mice; Mice, Inbred BALB C; Mycophenolic Acid; Oligonucleotide Array Sequence Analysis; Ribavirin; Ribonucleosides; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Specific Pathogen-Free Organisms; Vero Cells; Virus Replication	2006

Article

Year

Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.

Antiviral research, 2006, Volume: 71, Issue:1

Topics: Animals; Antiviral Agents; Caco-2 Cells; Cell Survival; Chlorocebus aethiops; Cytokines; Cytopathogenic Effect, Viral; Female; Humans; IMP Dehydrogenase; Lung; Mice; Mice, Inbred BALB C; Mycophenolic Acid; Oligonucleotide Array Sequence Analysis; Ribavirin; Ribonucleosides; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Specific Pathogen-Free Organisms; Vero Cells; Virus Replication

2006